Globus Medical (GMED) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.043x

Based on the latest financial reports, Globus Medical (GMED) has a cash flow conversion efficiency ratio of 0.043x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($202.36 Million) by net assets ($4.73 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Globus Medical defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Globus Medical - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Globus Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Globus Medical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Globus Medical ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Darling Ingredients Inc
NYSE:DAR
0.191x
Indoritel Makmur Internasional
JK:DNET
0.015x
Guobo Electronics Co. Ltd. A
SHG:688375
N/A
AKZO NOBEL SPONS.ADRS 1/3
F:AKUP
-0.017x
CITIC Metal Co. Ltd. A
SHG:601061
N/A
Subsea 7 S.A
F:SOCA
0.056x
National Retail Properties Inc
NYSE:NNN
0.029x
Persistent Systems Limited
NSE:PERSISTENT
0.052x

Annual Cash Flow Conversion Efficiency for Globus Medical (2010–2025)

The table below shows the annual cash flow conversion efficiency of Globus Medical from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see GMED company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $4.57 Billion $753.45 Million 0.165x +32.19%
2024-12-31 $4.18 Billion $520.64 Million 0.125x +104.63%
2023-12-31 $4.00 Billion $243.50 Million 0.061x -36.99%
2022-12-31 $1.85 Billion $178.47 Million 0.097x -39.07%
2021-12-31 $1.74 Billion $276.27 Million 0.159x +20.21%
2020-12-31 $1.51 Billion $198.79 Million 0.132x +7.63%
2019-12-31 $1.40 Billion $171.97 Million 0.123x -19.97%
2018-12-31 $1.19 Billion $181.64 Million 0.153x -7.05%
2017-12-31 $967.78 Million $159.53 Million 0.165x -20.20%
2016-12-31 $832.08 Million $171.89 Million 0.207x +21.17%
2015-12-31 $715.32 Million $121.96 Million 0.170x +26.07%
2014-12-31 $585.45 Million $79.17 Million 0.135x -31.66%
2013-12-31 $472.36 Million $93.47 Million 0.198x -0.05%
2012-12-31 $386.50 Million $76.52 Million 0.198x -26.81%
2011-12-31 $282.48 Million $76.41 Million 0.271x -13.41%
2010-12-31 $228.19 Million $71.29 Million 0.312x --

About Globus Medical

NYSE:GMED USA Medical Devices
Market Cap
$8.55 Billion
Market Cap Rank
#2527 Global
#908 in USA
Share Price
$75.42
Change (1 day)
-2.71%
52-Week Range
$51.89 - $96.82
All Time High
$96.82
About

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting… Read more